Published in Infection on June 26, 2000
Forest structure and roe deer abundance predict tick-borne encephalitis risk in Italy. PLoS One (2009) 1.35
Meta-analysis of all immune epitope data in the Flavivirus genus: inventory of current immune epitope data status in the context of virus immunity and immunopathology. Viral Immunol (2010) 1.14
Tick-borne flaviviruses: dissecting host immune responses and virus countermeasures. Immunol Res (2009) 0.97
Tick-borne encephalitis: A review of epidemiology, clinical characteristics, and management. World J Clin Cases (2015) 0.94
Diagnosis of tick-borne encephalitis by a mu-capture immunoglobulin M-enzyme immunoassay based on secreted recombinant antigen produced in insect cells. J Clin Microbiol (2003) 0.86
Tick-borne encephalitis: Clinical findings and prognosis in adults. Wien Med Wochenschr (2012) 0.81
Severe tick-borne encephalitis in Slovenia in the years 2001-2005: time for a mass vaccination campaign? Wien Klin Wochenschr (2006) 0.76
Author's reply: The first tick-borne encephalitis case in the Netherlands: reflections and a note of caution. Euro Surveill (2016) 0.75
Human Tick-Borne Encephalitis, the Netherlands. Emerg Infect Dis (2017) 0.75
Tick-borne viral encephalitis--the threat of summer. Infection (2000) 0.75
Clinical course and sequelae for tick-borne encephalitis among children in South Moravia (Czech Republic). Eur J Pediatr (2014) 0.75
Structural changes and functional control of the tick-borne encephalitis virus glycoprotein E by the heterodimeric association with protein prM. Virology (1994) 3.82
Antigenic structure of the flavivirus envelope protein E at the molecular level, using tick-borne encephalitis virus as a model. J Virol (1989) 2.59
Fusion activity of flaviviruses: comparison of mature and immature (prM-containing) tick-borne encephalitis virions. J Gen Virol (1991) 2.34
Spontaneous and engineered deletions in the 3' noncoding region of tick-borne encephalitis virus: construction of highly attenuated mutants of a flavivirus. J Virol (1998) 2.11
Durability of SVR in chronic hepatitis C patients treated with peginterferon-α2a/ribavirin in combination with a direct-acting anti-viral. Aliment Pharmacol Ther (2013) 2.04
Adaptation of tick-borne encephalitis virus to BHK-21 cells results in the formation of multiple heparan sulfate binding sites in the envelope protein and attenuation in vivo. J Virol (2001) 1.94
The flavivirus envelope protein E: isolation of a soluble form from tick-borne encephalitis virus and its crystallization. J Virol (1991) 1.80
Infectious cDNA clones of tick-borne encephalitis virus European subtype prototypic strain Neudoerfl and high virulence strain Hypr. J Gen Virol (1997) 1.79
Attenuation of tick-borne encephalitis virus by structure-based site-specific mutagenesis of a putative flavivirus receptor binding site. J Virol (2000) 1.77
In vitro-synthesized infectious RNA as an attenuated live vaccine in a flavivirus model. Nat Med (1998) 1.75
[Studies of the mechanism of the activity diminution of phosphoglucose isomerase in erythrocytes of patients with florid psoriasis vulgaris. I]. Arch Klin Exp Dermatol (1967) 1.61
Complete genomic sequence of Powassan virus: evaluation of genetic elements in tick-borne versus mosquito-borne flaviviruses. Virology (1993) 1.54
Hepatitis B virus (HBV) and hepatitis C virus (HCV) infections in health care workers (HCWs): guidelines for prevention of transmission of HBV and HCV from HCW to patients. J Clin Virol (2003) 1.53
[Remarks on the stroma reaction in melanoma]. Med Welt (1967) 1.35
[Dehydroepiandrosterone deficiency in psoriasis. Hypothesis on the etiopathogenesis of this disease]. Hautarzt (1980) 1.31
Characterization and complete genome sequences of high- and low- virulence variants of tick-borne encephalitis virus. J Gen Virol (1996) 1.28
Recombinant and virion-derived soluble and particulate immunogens for vaccination against tick-borne encephalitis. Vaccine (1995) 1.26
The interactions of the flavivirus envelope proteins: implications for virus entry and release. Arch Virol Suppl (1994) 1.20
An ongoing multi-state outbreak of measles linked to non-immune anthroposophic communities in Austria, Germany, and Norway, March-April 2008. Euro Surveill (2008) 1.18
Antibody-response to three recombinant hepatitis B vaccines: comparative evaluation of multicenter travel-clinic based experience. Vaccine (2001) 1.18
Sequence of the genes encoding the structural proteins of the low-virulence tick-borne flaviviruses Langat TP21 and Yelantsev. Virology (1991) 1.12
[On the activities of glucosephosphate isomerase in the blood and acetylcholinesterse in the blood and erythrocytes of patients with florid psoriasis vulgaris]. Arch Klin Exp Dermatol (1967) 1.12
[Studies of the activity of glucose phosphate isomerase in thrombocytes and leukocytes of patients with florid psoriasis vulgaria]. Klin Wochenschr (1967) 1.12
[Late disorders caused by arsenic in postmortem examined winegrowers of the Mosel region]. Med Welt (1969) 1.11
[Effect of gentamicin on the motility of Treponema pallidum]. Hautarzt (1969) 1.11
[Steroids and the skin. 8. In vitro experiments with 7 - 3 H-dehydroepiandrosterone and its sulfoconjugates on intact erythrocytes in psoriasis vulgaris]. Arch Dermatol Forsch (1972) 1.06
[Determination of myokinase and creatine phosphokinase in serum in experimental lathyrism, dermatomyositis and progessive scleroderma]. Arch Klin Exp Dermatol (1965) 1.05
Tick-borne encephalitis in dogs: neuropathological findings and distribution of antigen. Acta Neuropathol (1998) 1.03
Monitoring the virus load can predict the emergence of drug-resistant hepatitis B virus strains in renal transplantation patients during lamivudine therapy. J Infect Dis (2000) 1.02
[Etiopathogenesis of the psoriatic disease]. Med Welt (1973) 1.01
[Studies on the plasma DHEA content of psoriasis patients]. Z Haut Geschlechtskr (1970) 1.00
[The behavior of the "collagen-like protein" in serum of patients with seleroderma before and following treatment with gestagens]. Arch Klin Exp Dermatol (1967) 0.99
[Psoriasis, a systemic disease]. Internist (Berl) (1974) 0.98
[Detection of amyloid deposits in mycosis fungoides]. Arch Klin Exp Dermatol (1965) 0.98
[Lines of development in present scleroderma research]. Ergeb Inn Med Kinderheilkd (1966) 0.97
[Pericollagenous amyloid deposits in the skin and internal organs in scleroderma]. Klin Wochenschr (1969) 0.95
[Neurological and electrophysiological studies in progressive sclerodermia and morphea]. Arch Klin Exp Dermatol (1967) 0.95
[Studies on the quantitative behavior of collagen and non-collagen protein in human skin in relationship to age and site]. Arch Klin Exp Dermatol (1966) 0.95
[Electron microscopic studies of the skin in Darier's disease. II. The gradual process of dyskeratosis and the degeneration of pathological cell forms]. Z Haut Geschlechtskr (1967) 0.94
[Amyloid demonstration in the skin in mycosis fungoides]. Klin Wochenschr (1965) 0.93
[Organic manifestations of psoriasis]. Med Welt (1973) 0.93
[Steroids and the skin. VII. Excretion of C19 and C18 steroids in feces and urine following administration von (7 alpha-3H) 3 beta-hydroxy-5-androsterone-17-one(35S)sulfate to a patient with psoriasis vulgaris]. Hoppe Seylers Z Physiol Chem (1971) 0.93
[On research of psoriatic myopathies]. Arch Klin Exp Dermatol (1967) 0.93
["Collagen-like protein" content in serum of psoriatics]. Klin Wochenschr (1970) 0.93
[Observations and considerations in psoriasis as a multifactorial disease]. Arch Klin Exp Dermatol (1969) 0.92
[Electron microscopic study of the skin in Darier's disease. I. The early stages of acantholysis]. Z Haut Geschlechtskr (1967) 0.92
[Studies of the activity decrease of phosphoglucose isomerase in erythrocytes of patients with florid psoriasis vulgaris. 3]. Hautarzt (1967) 0.91
[On the therapy of scleroderma with gestagens]. Hautarzt (1965) 0.91
[Studies on the mechanical properties of human skin in relation to age and sex]. Arch Klin Exp Dermatol (1971) 0.91
[Steroids and skin. V. Plasma dehydroepiandrosterone and erythrocyte glucose-6-phosphate dehydrogenase activity in psoriatic patients before and after the administration of dehydroepiandrosterone sulfate]. Z Klin Chem Klin Biochem (1971) 0.90
[The place of lymphoscintigraphy in the treatment of malignant melanoma of the skin (author's transl)]. Dtsch Med Wochenschr (1982) 0.90
A new model of epidermal differentiation: induction by mechanical stimulation. Arch Dermatol Res (1990) 0.90
Fungal flora of human faeces in psoriasis and atopic dermatitis. Mycoses (1990) 0.90
[Hirsuties papillaris vulvae (pseudocondylomata of the vulva)]. Hautarzt (1982) 0.90
Exogenous and endogenous provocation of psoriasis. A contribution to the Koebner phenomenon. Arch Dermatol Forsch (1974) 0.89
[Zinc deficiency syndrome]. Dtsch Med Wochenschr (1979) 0.89
[Skin changes in long-term dialysis patients. clinical study]. Hautarzt (1982) 0.89
Measles outbreak linked to a minority group in Austria, 2008. Epidemiol Infect (2009) 0.89
[On humoral collagen-hints in pseudoxanthoma elasticum]. Arch Klin Exp Dermatol (1968) 0.89
[Enzyme distribution pattern in the serum of patients with psoriasis vulgaris I]. Arch Klin Exp Dermatol (1968) 0.88
[On Mg levels in serum and erythrocytes in patients with ichtyosis vulgaris]. Klin Wochenschr (1967) 0.88
[Therapy of psoriasis using dehydroepiandrosterone-enanthate]. Z Haut Geschlechtskr (1972) 0.88
[Steroids and skin. IX. On the metabolism of 7 - 3 H-DHEA sulfate in psoriasis]. Steroidologia (1971) 0.88
[Therapy of psoriasis using dehydroepiandrosterone-sulfate]. Arztl Forsch (1971) 0.87
[Demonstration of sorbite dehydrogenase in human erythrocytes]. Klin Wochenschr (1969) 0.86
[The activity of 17 beta-hydroxysteroid-oxidoreductase in erythrocytes of psoriatics (author's transl)]. Arch Dermatol Forsch (1974) 0.86
Studies on the metabolism of collagen. 3. The incorporation of [14C]glycine into the collagen of rats treated with progesterone. Biochem Z (1965) 0.86
[Electron microscopic studies of the skin in circumscript scleroderma]. Arch Klin Exp Dermatol (1967) 0.86
[Carbohydrate metabolism in psoriasis vulgaris]. Dtsch Med Wochenschr (1970) 0.86
[Organ findings in psoriasis]. Dtsch Med Wochenschr (1973) 0.86
[On the modification of serum and urinary mucopolysaccharides of patients with scleroderma using gestagen therapy]. Arch Klin Exp Dermatol (1968) 0.85
[High phospholipase A-activity of Candida albicans isolated from the intestines of psoriatic patients]. Mycoses (1988) 0.85
[Psoriasis arthropathica and amyloidosis]. Arch Dermatol Forsch (1972) 0.85
[Hyperinsulinism and limited glucose-tolerance in psoriasis]. Arch Dermatol Forsch (1972) 0.85
[Steroids and the skin. VI. Urinary excretion of C19-steroids in psoriatics]. Arch Dermatol Forsch (1971) 0.85
[Studies on the mechanism of the activity decrease of phosphoglucose isomerase in erythrocytes of patients with florid psoriasis vulgaris. II]. Arch Klin Exp Dermatol (1967) 0.85
[Family studies for detection of latent psoriatics by assay of alterations in steroid metabolism (author's transl)]. Arch Dermatol Forsch (1975) 0.84
[Mali's acroangiodermatitis (pseudo-Kaposi) in paralyzed legs]. Hautarzt (1988) 0.84
Steroids and skin. XI. C 19 -steroids in skin eluates from psoriatics. Horm Metab Res (1972) 0.84
[Cathepsin determination in rat serum after administration of progesterone and progesterone with prednisone]. Z Gesamte Exp Med (1965) 0.84
Quantitative determination of IgM antibodies reduces the pitfalls in the serodiagnosis of tick-borne encephalitis. J Clin Virol (2012) 0.84
[Enzyme distribution pattern in the serum of patients with psoriasis vulgaris II]. Arch Klin Exp Dermatol (1968) 0.83
[Can psoriasis be classified as a DHEA deficiency syndrome?]. Z Haut Geschlechtskr (1971) 0.83
[Oxygen consumption of erythrocytes from psoriatic patients]. Klin Wochenschr (1970) 0.83
[Studies on the percutaneous absorption of benzoyl peroxide (author's transl)]. Arzneimittelforschung (1982) 0.83
[On the problem of immunobiologic relations between lupus erythematosus disseminatus and progressive scleroderma]. Arch Klin Exp Dermatol (1967) 0.83
[Activity patterns of several enzymes of glucose degradation in the erythrocytes of patients with ichthyosis vulgaris]. Arch Klin Exp Dermatol (1966) 0.82
[Current views on the psoriasis problem]. Hippokrates (1972) 0.82
Transmission of hepatitis C virus in an orthopedic hospital ward. J Med Virol (2009) 0.82
Measles outbreak in Styria, Austria, March-May 2009. Euro Surveill (2009) 0.82
[Psoriasis and haemodialysis: changes in plasma hormone concentration as a possible therapeutic mechanism (author's transl)]. Dtsch Med Wochenschr (1981) 0.81
Carbonic anhydrase--a marker for fenestrated capillaries in psoriasis. Arch Dermatol Res (1992) 0.81
Morphological and functional findings of fixed phagocytes in psoriatics. Arch Dermatol Res (1983) 0.81
Transcription of melanogenesis enzymes in melanocytes: dependence upon culture conditions and co-cultivation with keratinocytes. Pigment Cell Res (1996) 0.81
Serum interferon level and (2'-5')oligoadenylate synthetase activity in lymphocytes during clinical interferon application. J Interferon Res (1985) 0.81
[On the influence of substances acting on connective tissue (beta-amino-propionitrile, progesterone and chloroquine) on the leucine aminopeptidase content in rat serum]. Arzneimittelforschung (1966) 0.81
[Eggshell-like calcification of enlarged hilus lymph nodes in progressive scleroderma]. Z Haut Geschlechtskr (1968) 0.81
[Value of human pharmacology test methods in the comparative assessment of topical corticosteroids]. Arch Klin Exp Dermatol (1969) 0.80
Functional studies of sessile macrophages in liver and spleen of psoriatics. Dermatologica (1983) 0.80
[HLA antigen frequencies in patients with progressive systemic sclerosis and morphea (author's transl)]. Arch Dermatol Res (1978) 0.80